XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Debt - Narrative (Details)
3 Months Ended 6 Months Ended 48 Months Ended
Mar. 17, 2017
USD ($)
Nov. 05, 2015
USD ($)
Apr. 01, 2015
d
conversion_right
$ / shares
Jan. 30, 2013
USD ($)
d
$ / shares
Jun. 30, 2017
USD ($)
institution
$ / shares
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
institution
$ / shares
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
institution
shares
Debt Instrument [Line Items]                  
Change in FV of embedded derivative income         $ (5,069,000) $ (4,872,000) $ (10,014,000) $ (4,734,000)  
Credit line capacity         191,078,000   191,078,000    
Goodwill         $ 712,075,000   $ 712,075,000   $ 704,603,000
Number of financial institutions | institution         11   11   10
BioReference                  
Debt Instrument [Line Items]                  
Net assets         $ 1,000,000,000   $ 1,000,000,000    
Goodwill         401,800,000   401,800,000    
Intangible assets         $ 467,600,000   $ 467,600,000    
OPKO Health Europe                  
Debt Instrument [Line Items]                  
Weighted average interest rate         3.10%   3.10%   3.20%
Minimum | OPKO Health Europe                  
Debt Instrument [Line Items]                  
Variable interest rates         1.80%   1.80%    
Maximum | OPKO Health Europe                  
Debt Instrument [Line Items]                  
Variable interest rates         6.30%   6.30%    
Notes                  
Debt Instrument [Line Items]                  
Long-term debt         $ 34,758,000   $ 34,758,000   $ 43,701,000
Notes | Notes Due February 1, 2033                  
Debt Instrument [Line Items]                  
Debt face amount       $ 175,000,000.0          
Interest rate on notes payable       3.00%          
Equivalent redemption price       100.00%          
Conversion price per share (in dollars per share) | $ / shares     $ 7.07 $ 7.07 $ 7.07   $ 7.07    
Convertible debt, threshold percentage of stock price trigger     130.00% 130.00%          
Number of trading days | d     20            
Conversion rate     0.1414827 0.14148     0.1414827    
Number of consecutive trading days applicable conversion price | d     30            
Conversion right triggered | conversion_right     1            
Common stock trigger price (in dollars per share) | $ / shares     $ 9.19            
Long-term debt         $ 31,900,000   $ 31,900,000    
Notes | Notes Due February 1, 2033 | Minimum                  
Debt Instrument [Line Items]                  
Number of trading days | d       20          
Notes | Notes Due February 1, 2033 | Maximum                  
Debt Instrument [Line Items]                  
Number of consecutive trading days applicable conversion price | d       30          
Notes | Notes Due February 1, 2033 | On or after February 1, 2017 and before February 1, 2019                  
Debt Instrument [Line Items]                  
Equivalent redemption price       100.00%          
Notes | Notes Due February 1, 2033 | On or after February 1, 2019                  
Debt Instrument [Line Items]                  
Equivalent redemption price       100.00%          
Convertible Debt | Notes Due February 1, 2033                  
Debt Instrument [Line Items]                  
Converted debt amount                 $ 143,200,000.0
Line of Credit                  
Debt Instrument [Line Items]                  
Weighted average interest rate         4.20%   4.20%   4.70%
Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity   $ 175,000,000.0              
Higher borrowing capacity option   $ 275,000,000.0              
Commitment fee percentage   0.25%              
Maximum intercompany loan $ 55,000,000                
Swingline | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity   $ 20,000,000.0              
Letter of Credit | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity   $ 20,000,000.0              
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate   2.50%              
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate   0.35%              
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate   0.50%              
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate   1.35%              
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate   1.50%              
Common Stock | Convertible Debt | Notes Due February 1, 2033                  
Debt Instrument [Line Items]                  
Shares issued on converted debt (in shares) | shares                 21,539,873